Confirmed Attendees & Roundtable Participants



Denny Ausiello, MD, Professor of Clinical Medicine at Harvard Medical School; Massachusetts General Hospital Physician-in-Chief, Emeritus; Lead Independent Director of Pfizer; and Scientific Advisory Board Member at PureTech Health

Mikael Dolsten, MD, PhD, President, Worldwide Research & Development and Executive Vice President of Pfizer, Inc.; member of the Pfizer Executive Leadership Team and the company’s Portfolio Strategy and Investment Committee; former President of Wyeth Research

Meghan FitzgeraldDrPH, Managing Partner at L1 Health LLC, Private Equity, a $2.5 billion capital and Assistant Professor at Columbia School of Public Health

Robert Horvitz, PhD, a recipient of the Nobel Prize in Physiology or Medicine; David H. Koch Professor of Biology at the Massachusetts Institute of Technology; an Investigator of the Howard Hughes Medical Institute, Neurobiologist (Neurology) at Massachusetts General Hospital; member of the M.I.T. McGovern Institute for Brain Research and the M.I.T. Koch Institute for Integrative Cancer Research; and Board Advisor and Scientific Advisory Board Chair at PureTech Health. 

Tom Lynch, MD, Executive Vice President and Chief Scientific Officer at Bristol-Myers Squibb; former chairman and Chief Executive Officer of Massachusetts General Physicians Organization and member of the MGH Board.

Daphne Zohar, Founder and CEO, Board Member of PureTech Health (PRTC.L), an advanced clinical stage biopharma company developing new categories of medicine at the interface of the brain-immune-gut axis.


Karen Bernstein, PhD, Co-Founder & Chairman of BioCentury, Inc

Martin Blaser, MD, Muriel and George Singer Professor of Medicine, Professor of Microbiology, and Director of the Human Microbiome Program at the NYU School of Medicine

Joe Bolen, PhD, Chief Scientific Officer at PureTech Health; former President and Chief Scientific Officer at Moderna Therapeutics; and former Chief Scientific Officer and Global Head of Oncology Research at Millennium

Michael Bonney, Chief Executive Officer and Chair at Kaleido Biosciences; Board Chair at Alnylam Pharmaceuticals; Board Member of Celgene and the Whitehead Institute for Biomedical Research; former CEO and Director at Cubist Pharmaceuticals

Stephen Brannan, MD, Chief Medical Officer at Karuna Pharmaceuticals (PureTech Health Affiliate)

Douglas Brodie, DPhil, Fund Manager and Partner at Baillie Gifford

Bharatt Chowrira, PhD, JD, President and Chief of Business and Strategy at PureTech Health

Hans Clevers, MD, PhD, Professor of Molecular Genetics at Hubrecht Institute/University Medical Center Utrecht and President of ISSCR

Daniel Couto, Chief Technical Officer at Vedanta Biosciences (PureTech Health Affiliate)

Michael T. Darda, Chief Economist/Chief Strategist & Director of Research at MKM Partners

Mark Davis, PhD, Professor, Microbiology & Immunology, Director at Stanford Institute for Immunity, Transplantation and Infection 

Carl Decicco, Senior Vice President, Head of Discovery at Bristol-Meyers Squibb

Maria Gloria Dominguez-Bello, PhD, Associate Professor in the Department of Medicine at the NYU School of Medicine

Eric Elenko, Chief of Research and Strategy at PureTech Health

Brett Finlay, PhD, Professor in the Michael Smith Laboratories, the Departments of Biochemistry and Molecular Biology and Microbiology and Immunology at the University of British Columbia

Simone Fishburn, PhD, Editor at BioCentury Innovations

Chris Garabedian, Chairman and CEO at Xontogeny

Adam Gazzaley, MD, PhD, Founding Director of the Neuroscience Imaging Center at the University of California, San Francisco (UCSF); Director at UCSF Gazzaley Lab; and Akili Co-Founder

Mark Goldberg, MD, President and Chief Operating Officer at Parexel

Don Ingber, MD, PhD, Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University

Rakesh Jain, PhD, Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School and Director of the Steele Laboratories at Massachusetts General Hospital.

Jeff Karp, PhD, Associate Professor at Brigham and Women's Hospital, Harvard Medical School; Principal Faculty at the Harvard Stem Cell Institute; and Principal Investigator at Karp Lab

Vinod Khosla, Founder of Khosla Ventures and Co-Founder of Sun Microsystems

Jonathan Kipnis, PhD, Harrison Distinguished Professor and Chair, Department of Neuroscience, and Director of the Center for Brain Immunology and Glia at the University of Virginia School of Medicine

Sophie Kornowski-Bonnet, PhD, Global Head of Roche Partnering and a Member of the Roche Corporate Executive Committee

Daniel Krizek, Portfolio Manager at Surveyor Capital

Raju Kucherlapati, PhD, Paul C. Cabot Professor of Genetics and a Professor of Medicine at Harvard Medical School; and Independent Non-Executive Director, Scientific Advisory Board Member at PureTech Health

John LaMattina, PhD, Independent Non-Executive Director at PureTech Health;  former President of Pfizer Global Research and Development and Senior Vice President of Pfizer, Inc.

Andrew Levin, MD, PhD, Managing Director at RA Capital Management

Dan Littman, MD, PhD, Helen L. and Martin S. Kimmel Professor of Molecular Immunology and Professor of Pathology and Microbiology at New York University School of Medicine

Philippe Lopes-Fernandes, Senior Vice-President, Global Head of Business Development & Alliance Management for Merck KGaA

Carrie Mantha, MD, MBA,  Managing Director at Aporia Capital

Andrew Marshall, PhD, Chief Editor at Nature Biotechnology

Eddie Martucci, PhD, President and CEO at Akili Interactive (PureTech Health Affiliate)

Ruslan Medzhitov, PhD, Professor of Immunobiology at Yale University School of Medicine 

George Miller, MD, H.L. Pachter Professor in the Departments of Surgery and Cell Biology at New York University School of Medicine and Leader of NYU’s Cancer Immunology Program

Andrew Miller, PhD, President and Chief Executive Officer of Karuna Pharmaceuticals (PureTech Health Affiliate)

Joep Muijrers, PhD, Portfolio Manager and Partner at Life Science Partners

Siddhartha Mukherjee, MD, DPhil, Assistant Professor of Medicine at Columbia University and Pulitzer Prize-Winning Author of Emperor of all Maladies 

Stephen Muniz, JD, Chief Operating Officer and a Member of the Board of Directors at PureTech Health

David Nicholson, PhD, Executive Vice President and Chief Research & Development Officer at Allergan

Troy Norris, MBA, Managing Director at Valamont Advisors

Bernat Olle, PhD, Chief Executive Officer at Vedanta Biosciences (PureTech Health Affiliate)

David Pass, PharmD, Chief Operating Officer and Head of Commercial at Gelesis (PureTech Health Affiliate)

Scott Plevy, MD, Vice President, IBD Disease Area Stronghold Lead in Immunology Research and Development at Janssen

Andy Plump, MD, PhD, Chief Medical and Scientific Officer at Takeda Pharmaceuticals

John Reed, MD, PhD, Global Head of Pharma Research and Early Development at Roche

Daniel Reich, MD, PhD, Senior Investigator at National Institutes of Health (NIH) National Institute of Neurological Disorders and Strokes (NINDS)

Johan Renes, Parner and Patent Attorney at DLA Piper Nederland

Maria Rescigno, PhD, Professor and Director of the Dendritic Cell Biology and Immunotherapy Unit at European Institute of Oncology

Thomas Roth, PhD, Director of the Sleep Disorders and Research Center at Henry Ford Hospital

Alexander Rudensky, PhD, Chair of Immunology in the Sloan Kettering Institute; Director of the Ludwig Center for Cancer Immunotherapy at MSKCC; and Professor at MSKCC, the Rockefeller University, Cornell University, Gerstner Sloan Kettering Graduate School of Biomedical Sciences and at Weill Cornell Graduate School of Medical Sciences

Alfred Sandrock, MD, PhD, Executive Vice President and Chief Medical Officer at Biogen

Alessandro Sannino, PhD, Inventor at Gelesis (PureTech Health Affiliate) and Professor of Polymer Science and Technology at the University of Salento

Uwe Schoenbeck, PhD, Chief Scientific Officer and Senior Vice President, External Science and Innovation at Pfizer

Otello Stampacchia, PhD, Founder and Managing Director at Omega Funds

David Steinberg, MBA, Chief Innovation Officer at PureTech Health

Melody Swartz, PhD, Professor at Institute for Molecular Engineering and Ben May Department for Cancer Research at University of Chicago

Robert Urban, PhD, Global Head of Johnson & Johnson Innovation

Rehan Verjee, EVP, Chief Marketing and Strategy Officer, Member of the Healthcare Executive Committee at Merck Serono

Chris Viehbacher, Managing Partner of Gurnet Point Capital; former Chief Executive Officer of Sanofi; former Chairman of Genzyme

Ulrich von Andrian, MD, PhD, Professor of Immunopathology at Harvard Medical School

Ramnik Xavier, MD, PhD, Chief of Gastrointestinal Unit at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School

Elias Zerhouni, MD, President, Global Research & Development and a member of the Executive Committee for Sanofi

Yishai Zohar, Chief Executive Officer at Gelesis (PureTech Health Affiliate)